Fresh2 Group Limited (NASDAQ: FRES)
$2.85
+0.0900 ( +3.26% ) 10.1K
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.
Market Data
Open
$2.85
Previous close
$2.76
Volume
10.1K
Market cap
$6.61M
Day range
$2.56 - $2.92
52 week range
$2.50 - $41.80
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 1 | Jan 05, 2024 |
| 6-k | Quarterly Reports | 2 | Dec 15, 2023 |
| 6-k | Quarterly Reports | 7 | Dec 06, 2023 |
| 6-k | Quarterly Reports | 4 | Dec 04, 2023 |
| 6-k/a | Quarterly Reports | 105 | Dec 04, 2023 |
| 6-k | Quarterly Reports | 105 | Nov 09, 2023 |
| 6-k | Quarterly Reports | 8 | Sep 25, 2023 |
| 6-k | Quarterly Reports | 2 | Sep 12, 2023 |
| 6-k | Quarterly Reports | 1 | Aug 28, 2023 |
| 6-k | Quarterly Reports | 5 | Aug 21, 2023 |